Moody’s also affirmed the “Aa3” rating on Cedars Sinai’s $960 million of debt.
The rating assignment and affirmation are based on a number of factors, including Cedars-Sinai’s large size, strong reputation and excellent financial performance.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that Cedars-Sinai will continue to grow patient volumes and revenue.
More articles on healthcare finance:
MIPS breakdown: 7 must-know parts of the MACRA final rule
BuildMyBod launches price database for ASCs and other providers
Baltimore EDs see $80M spent on gunshot wounds over last 5 years
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
